Abstract

134 Background: Delivery of high-quality cancer care critically relies on the ability to measure and compare quality for continuous improvement. For esophageal cancer, operative mortality has traditionally been assessed at 30 days. Ninety-day mortality has been suggested as a more appropriate indicator of quality particularly after complex cancer surgery. Our objectives were to: 1) compare 30- and 90-day mortality rates after esophagectomy; 2) compare drivers of 30- and 90-day mortality; and 3) examine whether 90-day mortality affects hospital rankings. Methods: Esophagectomies for non-metastatic esophageal cancer patients diagnosed between 2007 and 2011 were identified in the National Cancer Data Base (NCDB). Mortality rates were examined by patient demographics, tumor characteristics and hospital procedural volume. Risk-adjusted hierarchical logistic regression models examined hospital performance for mortality. Results: 15,805 esophagectomy patients at 977 hospitals were available for analysis. Ninety-day overall mortality was more than double the 30-day mortality (8.9% vs 4.2%, p<0.0001). In multivariate analysis, while both 30- and 90-day mortality were associated with patient factors such as age, comorbidity and hospital volume, only 90-day mortality was influenced by tumor and management related variables such as stage, tumor location and receipt of neoadjuvant therapy. Hospital performance was examined as top 10%, middle 10-90% and lowest 10% as ranked using risk-adjusted odds of mortality. There was moderate correlation between ranking based on 30- and 90-day mortality [weighted kappa = 0.45 (95% CI 0.39 - 0.52)]. Compared to 30-day mortality rankings, nearly 20% of hospitals changed their ranking category when 90-day mortality rankings were used. Conclusions: Ninety-day mortality provides additional information for surgical risk assessment and has the potential to greatly enhance data for quality improvement efforts. Data provided for hospital quality improvement should include 90-day mortality, along with 30-day mortality and annual volume.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.